How to Develop and Implement a National Drug Policy (Second Edition)
(2001; 96 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentContributors
View the documentAbbreviations and acronyms
View the documentPreface
Open this folder and view contentsPart I: How to develop and implement a national drug policy
Close this folderPart II: Key components of a national drug policy
Open this folder and view contents4. Selection of essential drugs
Open this folder and view contents5. Affordability
Open this folder and view contents6. Drug financing
Open this folder and view contents7. Supply systems
Open this folder and view contents8. Drug regulation
Close this folder9. Rational use of drugs
View the document9.1 Why is it important to promote rational use?
View the document9.2 Challenges
View the document9.3 Planning for activities to promote rational use of drugs
View the document9.4 Core strategies to improve drug use
View the document9.5 Educational strategies
View the document9.6 Managerial strategies to promote rational drug use
View the document9.7 Regulatory strategies to promote rational drug use
View the document9.8 Promoting rational drug use in the private sector
Open this folder and view contents10. Research
Open this folder and view contents11. Human resources development
Open this folder and view contents12. Monitoring and evaluation
View the documentReferences
View the documentSelected WHO publications and documents of related interest
View the documentBack cover
 

9.7 Regulatory strategies to promote rational drug use

A well-functioning regulatory system that ensures the efficacy, safety and quality of drugs marketed is a prerequisite for policies to promote rational use. There are various regulatory strategies that support educational and managerial strategies to promote rational drug use. Most have already been discussed in Chapter 8.

Evaluation of drugs for market approval and scheduling

The critical evaluation and rational selection of drugs registered for marketing in the country are among the main vehicles for limiting the availability and irrational use of drugs in the private sector. Scheduling decisions about which drugs are available “over-the-counter” to consumers and which are available “on prescription only” are important in determining how drugs are used, provided that they are enforced (which is, unfortunately, very often not the case). Regulations may be used to allow certain types of drugs to be prescribed by trained paramedical workers, such as nurses and midwives.

Drug promotion

Rational use of drugs is dependent upon people understanding that medicines should be used only when needed, for the correct indications and in the required dosage. Drug promotion influences prescribers and consumers, and regulations to control it are vital to increasing rational drug use. The WHO Ethical criteria for medicinal drug promotion58 can be used as a basis for developing such regulations. Promotion should be in line with national health policies, and comply with national regulations and any existing voluntary standards. For further information see Chapter 8.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014